Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-05-19

Clinical Trial Update: Effects of Steroid Tapering on Functional Capacity and Neurocognition [NA]

View source ↗

Summary

Duke University-sponsored trial evaluating steroid tapering effects on functional capacity and neurocognition in glioblastoma patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Glioblastoma Multiforme | NA | Status: WITHDRAWN